Artiva Biotherapeutics' CEO Fred Aslan, MD, discusses the concept of an immune reset and what the company is tracking in ...

Artiva Biotherapeutics' CEO Fred Aslan, MD, discusses two ongoing trials for autoimmunity indications in the US and how AlloNK differs from traditional B-cell depletion strategies.

The Grammy-award winner was diagnosed with lupus in 2014 Nathan Vinson is the Weekend Audience Editor for PEOPLE.com, where he oversees PEOPLE's social media channels, newsletters and ...

The new data show "robust benefit in lupus and DM,” William Blair analysts ... multiple sclerosis and pemphigus vulgaris (PV) across 50 sites in the U.S. and Europe. The biotech plans to share ...